Xu MQ - Search Results

1

Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells.

Zhang S, Li ZT, Liu M, Wang JR, Xu MQ, Li ZY, Duan XC, Hao YL, Zheng XC, Li H, Feng ZH, Zhang X. Zhang S, et al. Among authors: xu mq. J Control Release. 2019 Feb 10;295:102-117. doi: 10.1016/j.jconrel.2018.12.034. Epub 2018 Dec 21. J Control Release. 2019. PMID: 30582952

2

Improving Solubility and Oral Bioavailability of Febuxostat by Polymer-Coated Nanomatrix.

Yin YF, Guo Y, Song WD, Duan XC, Zheng XC, Zhong T, Zhang S, Yao X, Xu MQ, Zhang Q, Zhang X. Yin YF, et al. Among authors: xu mq. AAPS PharmSciTech. 2018 Feb;19(2):934-940. doi: 10.1208/s12249-017-0905-z. Epub 2017 Oct 27. AAPS PharmSciTech. 2018. PMID: 29079988

3

Effect of XlogP and Hansen Solubility Parameters on Small Molecule Modified Paclitaxel Anticancer Drug Conjugates Self-Assembled into Nanoparticles.

Zhong T, Hao YL, Yao X, Zhang S, Duan XC, Yin YF, Xu MQ, Guo Y, Li ZT, Zheng XC, Li H, Zhang X. Zhong T, et al. Among authors: xu mq. Bioconjug Chem. 2018 Feb 21;29(2):437-444. doi: 10.1021/acs.bioconjchem.7b00767. Epub 2018 Jan 29. Bioconjug Chem. 2018. PMID: 29300459

4

The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.

Zheng XC, Ren W, Zhang S, Zhong T, Duan XC, Yin YF, Xu MQ, Hao YL, Li ZT, Li H, Liu M, Li ZY, Zhang X. Zheng XC, et al. Among authors: xu mq. Int J Nanomedicine. 2018 Mar 13;13:1495-1504. doi: 10.2147/IJN.S157082. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29559778 Free PMC article.

5

Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo.

Duan XC, Yao X, Zhang S, Xu MQ, Hao YL, Li ZT, Zheng XC, Liu M, Li ZY, Li H, Wang JR, Feng ZH, Zhang X. Duan XC, et al. Among authors: xu mq. Int J Nanomedicine. 2018 Dec 24;14:195-204. doi: 10.2147/IJN.S186556. eCollection 2019. Int J Nanomedicine. 2018. PMID: 30636872 Free PMC article.

6

Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.

Li ZY, Yin YF, Guo Y, Li H, Xu MQ, Liu M, Wang JR, Feng ZH, Duan XC, Zhang S, Zhang SQ, Wang GX, Liao A, Wang SM, Zhang X. Li ZY, et al. Among authors: xu mq. Int J Nanomedicine. 2020 Mar 16;15:1809-1821. doi: 10.2147/IJN.S240436. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32214813 Free PMC article.

7

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death.

Duan XC, Peng LY, Yao X, Xu MQ, Li H, Zhang SQ, Li ZY, Wang JR, Feng ZH, Wang GX, Liao A, Chen Y, Zhang X. Duan XC, et al. Among authors: xu mq. Drug Deliv. 2021 Dec;28(1):800-813. doi: 10.1080/10717544.2021.1909180. Drug Deliv. 2021. PMID: 33866918 Free PMC article.

8

Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles.

Xu MQ, Zhong T, Yao X, Li ZY, Li H, Wang JR, Feng ZH, Zhang X. Xu MQ, et al. Drug Deliv. 2021 Dec;28(1):1603-1615. doi: 10.1080/10717544.2021.1958107. Drug Deliv. 2021. PMID: 34319209 Free PMC article.

9

A combination strategy based on an Au nanorod/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle.

Feng ZH, Li ZT, Zhang S, Wang JR, Li ZY, Xu MQ, Li H, Zhang SQ, Wang GX, Liao A, Zhang X. Feng ZH, et al. Among authors: xu mq. Acta Biomater. 2021 Dec;136:495-507. doi: 10.1016/j.actbio.2021.09.052. Epub 2021 Oct 5. Acta Biomater. 2021. PMID: 34619371

10

Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo.

Xu MQ, Hao YL, Wang JR, Li ZY, Li H, Feng ZH, Wang H, Wang JW, Zhang X. Xu MQ, et al. Int J Nanomedicine. 2021 Oct 27;16:7269-7281. doi: 10.2147/IJN.S331578. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34737564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters